Indications
Therapeutic Asset Ratings
6,299 results matching 1 filter
91,565
assets
·
7,904
sponsors
·
3,128
indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
rr001
Pancreatic Adenocarcinoma
EIR Biotherapies s.r.l.
P1/2
CC
(45)
Rtx-224
Cutaneous Melanoma
Rubius Therapeutics
P1/2
CC
(45)
Ruxolitinib
Castration-Resistant Prostate Carcinoma
University of Michigan Rogel Cancer Center
P1/2
CC
(45)
Ruxolitinib
Precursor B-Cell Acute Lymphoblastic Leukemia
Princess Maxima Center for Pediatric Oncology
P1/2
CC
(45)
s241656
Carcinoma
Institut de Recherches Internationales Servier
P1/2
CC
(45)
s241656
Thyroid Cancer
Institut de Recherches Internationales Servier
P1/2
CC
(45)
Sacituzumab Tirumotecan
Esophageal Cancer
Merck Sharp & Dohme LLC
P1/2
CC
(45)
Sarcoma-Specific Car-T Cells
Ewing Sarcoma
Shenzhen Geno-Immune Medical Institute
P1/2
CC
(45)
Sarilumab
Breast Disorder
University of Southern California
P1/2
CC
(45)
Saruparib
Squamous Cell Lung Carcinoma
AstraZeneca
P1/2
CC
(45)
Saruparib
Pancreatic Neoplasm
AstraZeneca
P1/2
CC
(45)
sb-4826
Non-Hodgkin Lymphoma
University of California, San Diego
P1/2
CC
(45)
sbt6290
Head And Neck Squamous Cell Carcinoma
Silverback Therapeutics
P1/2
CC
(45)
scg142
Anal Squamous Cell Carcinoma
SCG Cell Therapy Pte. Ltd.
P1/2
CC
(45)
scg142
Human Papillomavirus-Related Penile Squamous Cell Carcinoma
SCG Cell Therapy Pte. Ltd.
P1/2
CC
(45)
scg142
Vulvar Squamous Cell Carcinoma
SCG Cell Therapy Pte. Ltd.
P1/2
CC
(45)
Selpercatinib
Congenital Fibrosarcoma
Eli Lilly and Company
P1/2
CC
(45)
Shr-4394
Prostate Cancer
Jiangsu HengRui Medicine Co., Ltd.
P1/2
CC
(45)
Simmitinib
Cancer
Shanghai Runshi Pharmaceutical Technology Co., Ltd
P1/2
CC
(45)
SL-28
Lung Adenocarcinoma
Second Life Therapeutics
P1/2
CC
(45)
SL-28
Non-Small Cell Lung Carcinoma
Second Life Therapeutics
P1/2
CC
(45)
SL-28
Cutaneous Melanoma
Second Life Therapeutics
P1/2
CC
(45)
SL-28
Renal Cell Carcinoma
Second Life Therapeutics
P1/2
CC
(45)
Son-1010
Ovarian Cancer
Sonnet BioTherapeutics
P1/2
CC
(45)
Sonrotoclax
Myelodysplastic/Myeloproliferative Neoplasm
BeiGene
P1/2
CC
(45)
Showing 3801 to 3825 of 6,299 assets
Previous
Page 153 of 252
Next